GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Median Technologies (XPAR:ALMDT) » Definitions » 3-Year FCF Growth Rate

Median Technologies (XPAR:ALMDT) 3-Year FCF Growth Rate : -34.60% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Median Technologies 3-Year FCF Growth Rate?

Median Technologies's Free Cash Flow per Share for the six months ended in Dec. 2023 was €-0.42.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -34.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -11.50% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Median Technologies was 22.80% per year. The lowest was -55.30% per year. And the median was -13.55% per year.


Competitive Comparison of Median Technologies's 3-Year FCF Growth Rate

For the Medical Devices subindustry, Median Technologies's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Median Technologies's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Median Technologies's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Median Technologies's 3-Year FCF Growth Rate falls into.



Median Technologies 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Median Technologies  (XPAR:ALMDT) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Median Technologies 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Median Technologies's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Median Technologies (XPAR:ALMDT) Business Description

Traded in Other Exchanges
Address
1800 Route Des Cretes, Les Deux Arcs B, Valbonne, FRA, 06560
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and iBiopsy for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Its geographical segments are France, the USA/Canada, the United Kingdom, China, and Other countries.

Median Technologies (XPAR:ALMDT) Headlines

No Headlines